Authored by Ke-Chih Lin, et al., and presented at SLAS 2023
Find out how Opto™ Plasma B Discovery on the Beacon optofluidic system allows CROs to scale their business and rapidly deliver lead molecules even against difficult targets.
Explore case studies for the rapid discovery of antibodies against challenging targets.